Joseph Talamo - 11 Dec 2023 Form 4 Insider Report for INTENSITY THERAPEUTICS, INC. (INTS)

Role
Chief Financial Officer
Signature
/s/ Daniel L. Woodard, Attorney-in-Fact
Issuer symbol
INTS
Transactions as of
11 Dec 2023
Net transactions value
$0
Form type
4
Filing time
12 Dec 2023, 08:17:04 UTC
Next filing
23 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INTS Stock Option (right to buy Common Stock) Award $0 +80,000 $0.000000 80,000 11 Dec 2023 Common Stock 80,000 $6.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in four equal, annual installments, beginning on December 11, 2024.